{"protocolSection":{"identificationModule":{"nctId":"NCT06348199","orgStudyIdInfo":{"id":"SB27-3004"},"organization":{"fullName":"Samsung Bioepis Co., Ltd.","class":"INDUSTRY"},"briefTitle":"A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer","officialTitle":"A Phase III Randomised, Double-blind, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 (Proposed Pembrolizumab Biosimilar) and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer"},"statusModule":{"statusVerifiedDate":"2025-06","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-03-12","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-09","type":"ESTIMATED"},"completionDateStruct":{"date":"2027-03","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-03-28","studyFirstSubmitQcDate":"2024-03-28","studyFirstPostDateStruct":{"date":"2024-04-04","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-06-26","lastUpdatePostDateStruct":{"date":"2025-06-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Samsung Bioepis Co., Ltd.","class":"INDUSTRY"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The goal of this clinical trial is to confirm that SB27 works in the same way as Keytruda in metastatic non-squamous non-small cell lung cancer (NSCLC) patients. The main question it aims to answer is:\n\n• How effective the study drug is Participants will receive either investigational product (SB27 or Keytruda) and chemotherapy every 3 weeks.\n\nResearchers will compare SB27 and Keytruda to see if SB27 works in the same way as Keytruda."},"conditionsModule":{"conditions":["Non-small Cell Lung Cancer Stage IV"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":616,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"SB27","type":"EXPERIMENTAL","description":"SB27 will be administered followed by Pemetrexed and Carboplatin (Carboplatin will be administered for the first 4 cycles).","interventionNames":["Drug: SB27"]},{"label":"Keytruda","type":"ACTIVE_COMPARATOR","description":"Keytruda will be administered followed by Pemetrexed and Carboplatin (Carboplatin will be administered for the first 4 cycles).","interventionNames":["Drug: Keytruda"]}],"interventions":[{"type":"DRUG","name":"SB27","description":"Will be administered intravenously at a fixed dose of 200 mg every 3 weeks","armGroupLabels":["SB27"]},{"type":"DRUG","name":"Keytruda","description":"Will be administered intravenously at a fixed dose of 200 mg every 3 weeks","armGroupLabels":["Keytruda"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Objective response rate (ORR) at Week 24","description":"Defined as the proportion of subjects achieving a complete response (CR) or partial response (PR) at Week 24 according to RECIST v1.1","timeFrame":"At Week 24"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female ≥ 18 years of age\n* Have been diagnosed with stage IV non-squamous NSCLC\n* Have not received any prior systemic anti-cancer therapy for metastatic NSCLC\n* Agree to use adequate methods of contraception\n\nExclusion Criteria:\n\n* Unable or unwilling to take folic acid and vitamin B12 supplementation\n* Severe hypersensitivity to treatment with another monoclonal antibody, any ingredient contained in SB27 or Keytruda, or any component of platinum-containing compounds or pemetrexed.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Samsung Bioepis","role":"CONTACT","phone":"+82-32-728-0371","email":"sbregistry@samsung.com"}],"locations":[{"facility":"SB Investigative Site","status":"RECRUITING","city":"Banja Luka","country":"Bosnia and Herzegovina","geoPoint":{"lat":44.77842,"lon":17.19386}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Mostar","country":"Bosnia and Herzegovina","geoPoint":{"lat":43.34333,"lon":17.80806}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Sarajevo","country":"Bosnia and Herzegovina","geoPoint":{"lat":43.84864,"lon":18.35644}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Curitiba","country":"Brazil","geoPoint":{"lat":-25.42778,"lon":-49.27306}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Florianópolis","country":"Brazil","geoPoint":{"lat":-27.59667,"lon":-48.54917}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Ijui","country":"Brazil","geoPoint":{"lat":-28.38778,"lon":-53.91472}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Natal","country":"Brazil","geoPoint":{"lat":-5.795,"lon":-35.20944}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Pelotas","country":"Brazil","geoPoint":{"lat":-31.77194,"lon":-52.3425}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Porto Alegre","country":"Brazil","geoPoint":{"lat":-30.03306,"lon":-51.23}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Rio De Janeiro","country":"Brazil","geoPoint":{"lat":-22.90278,"lon":-43.2075}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Santo André","country":"Brazil","geoPoint":{"lat":-23.66389,"lon":-46.53833}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Batumi","country":"Georgia","geoPoint":{"lat":41.64228,"lon":41.63392}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Tbilisi","country":"Georgia","geoPoint":{"lat":41.69411,"lon":44.83368}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Düsseldorf","country":"Germany","geoPoint":{"lat":51.22172,"lon":6.77616}},{"facility":"SB Investigative Site","status":"WITHDRAWN","city":"Giessen","country":"Germany","geoPoint":{"lat":50.58727,"lon":8.67554}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Halle","country":"Germany","geoPoint":{"lat":51.48159,"lon":11.97948}},{"facility":"SB Investigative Site","status":"WITHDRAWN","city":"Kassel","country":"Germany","geoPoint":{"lat":51.31667,"lon":9.5}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Moers","country":"Germany","geoPoint":{"lat":51.45342,"lon":6.6326}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Neuss","country":"Germany","geoPoint":{"lat":51.19807,"lon":6.68504}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Bangalore","country":"India","geoPoint":{"lat":12.97194,"lon":77.59369}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Bhubaneshwar","country":"India","geoPoint":{"lat":20.27241,"lon":85.83385}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Bhubaneswar","country":"India","geoPoint":{"lat":20.27241,"lon":85.83385}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Erandwane","country":"India"},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Hyderabad","country":"India","geoPoint":{"lat":17.38405,"lon":78.45636}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Jaipur","country":"India","geoPoint":{"lat":26.91962,"lon":75.78781}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Mumbai","country":"India","geoPoint":{"lat":19.07283,"lon":72.88261}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Sūrat","country":"India","geoPoint":{"lat":21.19594,"lon":72.83023}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Udaipur","country":"India","geoPoint":{"lat":24.58584,"lon":73.71346}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Himeji","country":"Japan","geoPoint":{"lat":34.81667,"lon":134.7}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Iwakuni","country":"Japan","geoPoint":{"lat":34.16297,"lon":132.22}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Izumi","country":"Japan","geoPoint":{"lat":34.48333,"lon":135.43333}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Kawachi-Nagano","country":"Japan","geoPoint":{"lat":34.44108,"lon":135.58283}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Kobe","country":"Japan","geoPoint":{"lat":34.6913,"lon":135.183}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Kochi","country":"Japan","geoPoint":{"lat":33.55,"lon":133.53333}},{"facility":"SB Investigative Site","status":"WITHDRAWN","city":"Okayama","country":"Japan","geoPoint":{"lat":34.65,"lon":133.93333}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Sagamihara","country":"Japan","geoPoint":{"lat":35.54899,"lon":139.26064}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Tachikawa","country":"Japan"},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Takarazuka","country":"Japan","geoPoint":{"lat":34.79936,"lon":135.35697}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Toyonaka","country":"Japan","geoPoint":{"lat":34.78244,"lon":135.46932}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"George Town","country":"Malaysia","geoPoint":{"lat":5.41123,"lon":100.33543}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Johor Bahru","country":"Malaysia","geoPoint":{"lat":1.4655,"lon":103.7578}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Kota Bharu","country":"Malaysia","geoPoint":{"lat":6.13328,"lon":102.2386}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Kuantan","country":"Malaysia","geoPoint":{"lat":3.8077,"lon":103.326}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Lembah Pantai","country":"Malaysia"},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Putrajaya","country":"Malaysia","geoPoint":{"lat":2.93527,"lon":101.69112}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Aguascalientes","country":"Mexico","geoPoint":{"lat":21.88234,"lon":-102.28259}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Ciudad De México","country":"Mexico","geoPoint":{"lat":19.42847,"lon":-99.12766}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Guadalajara","country":"Mexico","geoPoint":{"lat":20.66682,"lon":-103.39182}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Davao City","country":"Philippines","geoPoint":{"lat":7.07306,"lon":125.61278}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Makati City","country":"Philippines","geoPoint":{"lat":14.55027,"lon":121.03269}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Manila","country":"Philippines","geoPoint":{"lat":14.6042,"lon":120.9822}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Quezon City","country":"Philippines","geoPoint":{"lat":14.6488,"lon":121.0509}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"San Juan City","country":"Philippines","geoPoint":{"lat":14.6,"lon":121.0333}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Cluj-Napoca","country":"Romania","geoPoint":{"lat":46.76667,"lon":23.6}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Craiova","country":"Romania","geoPoint":{"lat":44.31667,"lon":23.8}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Iaşi","country":"Romania","geoPoint":{"lat":47.16667,"lon":27.6}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Oradea","country":"Romania","geoPoint":{"lat":47.0458,"lon":21.91833}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Sibiu","country":"Romania","geoPoint":{"lat":45.8,"lon":24.15}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Suceava","country":"Romania","geoPoint":{"lat":47.63333,"lon":26.25}},{"facility":"SB Investigative Site","status":"WITHDRAWN","city":"Timişoara","country":"Romania","geoPoint":{"lat":45.75372,"lon":21.22571}},{"facility":"SB Investigative Site","status":"WITHDRAWN","city":"Târgu-Mureş","country":"Romania","geoPoint":{"lat":46.54245,"lon":24.55747}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Belgrade","country":"Serbia","geoPoint":{"lat":44.80401,"lon":20.46513}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Kragujevac","country":"Serbia","geoPoint":{"lat":44.01667,"lon":20.91667}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Nis","country":"Serbia","geoPoint":{"lat":43.32472,"lon":21.90333}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Sremska Kamenica","country":"Serbia","geoPoint":{"lat":45.22158,"lon":19.84367}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Leganés","country":"Spain","geoPoint":{"lat":40.32718,"lon":-3.7635}},{"facility":"SB Investigative Site","status":"WITHDRAWN","city":"Madrid","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Málaga","country":"Spain","geoPoint":{"lat":36.72016,"lon":-4.42034}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Ourense","country":"Spain","geoPoint":{"lat":42.33669,"lon":-7.86407}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Oviedo","country":"Spain","geoPoint":{"lat":43.36029,"lon":-5.84476}},{"facility":"SB Investigative Site","status":"WITHDRAWN","city":"Pamplona","country":"Spain","geoPoint":{"lat":42.81687,"lon":-1.64323}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Santiago De Compostela","country":"Spain","geoPoint":{"lat":42.88052,"lon":-8.54569}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Sevilla","country":"Spain","geoPoint":{"lat":37.38283,"lon":-5.97317}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Valencia","country":"Spain","geoPoint":{"lat":39.46975,"lon":-0.37739}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Bangkok Noi","country":"Thailand","geoPoint":{"lat":13.76266,"lon":100.47798}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Bangkok","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Khon Kaen","country":"Thailand","geoPoint":{"lat":16.44671,"lon":102.833}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Adapazarı","country":"Turkey","geoPoint":{"lat":40.78056,"lon":30.40333}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Ankara","country":"Turkey","geoPoint":{"lat":39.91987,"lon":32.85427}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Balgat","country":"Turkey","geoPoint":{"lat":39.9058,"lon":32.81907}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Bağcılar","country":"Turkey","geoPoint":{"lat":41.03903,"lon":28.85671}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Cubuk","country":"Turkey","geoPoint":{"lat":40.23861,"lon":33.03222}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Istanbul","country":"Turkey","geoPoint":{"lat":41.01384,"lon":28.94966}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Izmit","country":"Turkey","geoPoint":{"lat":40.76694,"lon":29.91694}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Kavaklıdere","country":"Turkey","geoPoint":{"lat":37.44463,"lon":28.36276}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Konak","country":"Turkey"},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Maltepe","country":"Turkey","geoPoint":{"lat":40.93567,"lon":29.15507}},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Seyhan","country":"Turkey"},{"facility":"SB Investigative Site","status":"RECRUITING","city":"Sivas","country":"Turkey","geoPoint":{"lat":39.74833,"lon":37.01611}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-07-07"},"conditionBrowseModule":{"meshes":[{"id":"D008175","term":"Lung Neoplasms"},{"id":"D002289","term":"Carcinoma, Non-Small-Cell Lung"}],"ancestors":[{"id":"D012142","term":"Respiratory Tract Neoplasms"},{"id":"D013899","term":"Thoracic Neoplasms"},{"id":"D009371","term":"Neoplasms by Site"},{"id":"D009369","term":"Neoplasms"},{"id":"D008171","term":"Lung Diseases"},{"id":"D012140","term":"Respiratory Tract Diseases"},{"id":"D002283","term":"Carcinoma, Bronchogenic"},{"id":"D001984","term":"Bronchial Neoplasms"}],"browseLeaves":[{"id":"M11172","name":"Lung Neoplasms","asFound":"Lung Cancer","relevance":"HIGH"},{"id":"M5546","name":"Carcinoma, Non-Small-Cell Lung","asFound":"Non-small Cell Lung Cancer","relevance":"HIGH"},{"id":"M5534","name":"Carcinoma","relevance":"LOW"},{"id":"M14979","name":"Respiratory Tract Neoplasms","relevance":"LOW"},{"id":"M16658","name":"Thoracic Neoplasms","relevance":"LOW"},{"id":"M11168","name":"Lung Diseases","relevance":"LOW"},{"id":"M14977","name":"Respiratory Tract Diseases","relevance":"LOW"},{"id":"M5540","name":"Carcinoma, Bronchogenic","relevance":"LOW"},{"id":"M5260","name":"Bronchial Neoplasms","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC04","name":"Neoplasms"},{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"All","name":"All Conditions"}]},"interventionBrowseModule":{"meshes":[{"id":"C582435","term":"Pembrolizumab"}],"ancestors":[{"id":"D000074322","term":"Antineoplastic Agents, Immunological"},{"id":"D000970","term":"Antineoplastic Agents"},{"id":"D000082082","term":"Immune Checkpoint Inhibitors"},{"id":"D045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M18650","name":"Carboplatin","relevance":"LOW"},{"id":"M264","name":"Pemetrexed","relevance":"LOW"},{"id":"M349416","name":"Pembrolizumab","asFound":"PET","relevance":"HIGH"},{"id":"M1346","name":"Antineoplastic Agents, Immunological","relevance":"LOW"},{"id":"M2342","name":"Immune Checkpoint Inhibitors","relevance":"LOW"}],"browseBranches":[{"abbrev":"ANeo","name":"Antineoplastic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}